GPS: Clínica Médica
Bibliografia Sugerida
[No authors listed]. Using beta 2-stimulants in asthma. Drug Ther Bull. 1997; 35(1):1-4.
Aaron S, Donaldson GC, Whitmore G, Hurst JR, Ramsay T, Wedzicha JA. Time course and pattern of
COPD exacerbation onset. Thorax [Internet]. 2012; 67(3):238-43.
Agnelli G, Becattini C. Acute Pulmonary Embolism. N Engl J Med. 2010; 363(3):266-74.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M et al. Apixaban for Extended Treatment
of Venous Thromboembolism. N Engl J Med. 2012 Dec 8 [Epub ahead of print].
Anderson FA Jr, Spencer FA. Risk factors for venous thromboem-bolism. Circulation. 2003; 107(23
Suppl 1):19-16.
Barreto SSM, Fiterman J, Lima MA (eds). Prática pneumológica. Rio de Janeiro: Guanabara Koogan,
2010. 15:211-24.
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al. Global strategy for asthma
management and prevention: GINA executive summary. Eur Respir J. 2008 Jan; 31(1): 143-78.
Battleman DS. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital
stay of patients with community-acquired pneumonia: link between quality of care and
resource utilization Arch Intern Méd. 2002; 162(6):682-8.
Bestall JC, Paul E, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research
Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive
pulmonary disease. Thorax [Internet]. 1999 Jul; 54(7):581-6.
Bjerre LM, Verheij Theo JM, Kochen MM. Antibiotics for community acquired pneumonia in adult
outpatients. Cochrane Database of Systematic Reviews, Issue 3, 2009.
Blot SI, Rodriguez A, Solé-Violán J, Blanquer J, Almirall J, Rello J. Effects of delayed oxygenation
assessment on time to antibiotic delivery and mortality in patients with severe community-
acquired pneumonia. Crit Care Med. 2007; 35(11):DOI: 10.1097/01.CCM.0000287587.43801.9C
Bouros D, Noppen M. Update on pleural disease: introduction. Respiration. 2008; 75(1):2-3.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Manual de recomendações para o
controle da tuberculose no Brasil. Brasília: MS, 2011.
Burgel P, Nesme-Meyer P, Chanez P, Caillaud D, Carré P, Perez T et al. Cough and sputum production are
associated with frequent exacerbations and hospitalizations in COPD subjects. Chest [Internet].
2009 Apr [cited 2010 Aug 9]; 135(4):975-82.
Cabral AL, Carvalho WA, Chinen M, Barbiroto RM, Boueri FM, Martins MA. Are International Asthma
Guidelines effective for low-income Brazilian children with asthma? Eur Respir J. 1998 Jul;
12(1):35-40.
Carrier M, Righini M, Djurabi RK, Huisman MV, Perrier A, Wells PS et al. VIDAS D-dimer in combination
with clinical pre-test probability to rule out pulmonary embolism. A systematic review of
management outcome studies. Thromb Haemost. 2009; 101(5):886-92.
Celli B, Barnes P. Exacerbations of chronic obstructive pulmonary disease. The European respiratory
journal: official journal of the European Society for Clinical Respiratory Physiology [Internet].
2007; 29(6):1224-38.
Cenci FB, Mainardi PB, Tonietto RG, Tonietto V. Derrame pleural na prática clínica. Acta méd (Porto
Alegre). 2011; 32:136-146.
Chapman KR, Verbeek PR, White JG, Rebuck AS. Effect of a short course of prednisone in the
prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med.
1991 Mar 21; 324(12):788-94.
Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJC, Hicks LA, Pankey GA, Seleznick M, Volturo
G, Wald ER, File Jr TM. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in
Children and Adults. Clinical Infectious Diseases. 2012; 54(8):1041-5.
Conde M, Fiterman J, Lima M. Tuberculose. Rio de Janeiro: AC Farmacêutica; 2011.
Conde MB, Pinheiro VGF, Marques AMC. Tuberculose. In: Menna Barreto SS. Prática pneumológica. Rio
de Janeiro: AC Farmacêutica; 2010. p. 270-94.
Correa R, Lundgren F, Pereira Silva J, Frare E Silva R, Cardoso A et al. Diretrizes brasileiras para
tratamento das pneumonias adquiridas no hospital e das associadas à ventilação mecânica. J
Brasil Pneumolol. 2007; 33(Supl 1 S)S1-30.
Correa RA, Pereira J, Teixeira P, Lundgren F. Diretrizes brasileiras para pneumonia adquirida na
comunidade em adultos imunocompetentes. J Bras Pneumolol. 2009; 35(6):574-601.
Crisafulli E, Gorgone P, Vagaggini B, Pagani M, Rossi G, Costa F et al. Efficacy of standard rehabilitation
in COPD outpatients with comorbidities. The European respiratory journal: official journal of the
European Society for Clinical Respiratory Physiology [Internet]. 2010 Nov [cited 2011 Jul 7];
36(5): 1042-8.
Cunha CA, Kuchiki MI. Diagnóstico e tratamento das infecções comunitárias comuns em adulto
imunocompetente. Parte I. Prat Hosp. 2007; 53:97-104.
da Silva Júnior CT (org). Diagnóstico e tratamento das doenças pleurais. Sociedade Brasileira de
Pneumologia e Tisiologia. Rio de Janeiro: AC Farmacêutica, 2013; 21:155-157.
Daniels JM, Snijders D, Graaff CS, Vlaspolder F, Jansen HM, Boersma WG. Antibiotics in addition to
systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine [Internet]. 2010 Jan; 181(2):150-7.
Deykin A, Wechsler ME, Boushey HA, Chinchilli VM, Kunselman SJ, Craig TJ et al. Combination therapy
with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir
Crit Care Med. 2007 Feb 1; 175(3):228-34.
Diaz-Guzman E, Budev MM. Accuracy of the physical examination in evaluating pleural effusion. Cleve
Clin J Med. 2008 Apr; 75(4):297-303.
Douma RA, Gibson NS, Gerdes VE, Büller HR, Wells PS, Perrier A et al. Validity and clinical utility of the
simpli ed Wells rule for assessing clinical probability for the exclusion of pulmonary embolism.
Thromb Haemost. 2009; 101:197-200.
Elicker B, Pereira CA, Webb R, Leslie KO. High-resolution computed tomography patterns of diffuse
interstitial lung disease with clinical and pathological correlation. J Bras Pneumol. 2008;
34(9):715-44.
Elliot GC. Pulmonary physiology during pulmonary embolism. Chest. 1992; 101(suppl 4): 163S-71S.
Esteban C, Arostegui I, Moraza J, Aburto M, Quintana JM, Pérez-Izquierdo J et al. Development of a
decision tree to assess the severity and prognosis of stable COPD. The European respiratory
journal: official journal of the European Society for Clinical Respiratory Physiology [Internet].
2011 Dec [cited 2012 Mar 20]; 38(6):1294-300.
European Society of Cardiology (ESC). European Heart Journal. 2008; 29(18):2276-315.
Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O’Connor BJ, Barnes PJ. A comparison of low-dose
inhaled budesonide plus theoph-ylline and high-dose inhaled budesonide for moderate
asthma. N Engl J Med. 1997 Nov 13; 337(20):1412-8.
Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G. New
perspectives on community-acquired pneumonia in 388 406 patients. Results from a
nationwide mandatory performance measurement programme in healthcare quality. Thorax.
2009; 64:1062-1069 doi:10.1136/thx.2008.109785
Fine MJ. A Predction rule to identify low-risk patients with community acquired pneumonia. N Engl J
Méd. 1997; 336:243-250.
Fine MJ. Risk strati cation for patients with community-acquired pneumonia Int J Clin Pract Suppl.
2000; 115:14-17.
Fischl MA, Pitchenik A, Gardner LB. An index predicting relapse and need for hospitalization in
patients with acute bronchial asthma. N Engl J Med. 1981 Oct 1; 305(14):783-9.
Franco R, Nascimento HF, Cruz AA, Santos AC, Souza-Machado C, Ponte EV et al. The economic impact
of severe asthma to low-income families. Allergy. 2009 Mar; 64(3):478-83.
Froudarakis ME. Diagnostic work-up of pleural effusions. Respiration. 2008; 75(1):4-13.
Gantz NM, Brown RB, Berk SL, James W. Manual of Clinical Problems in Infectious Disease. Fifth
Edition. Myers, Lippincott, Williams & Wilkins, 2006.
GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive
pulmonar disease. Global Initiative for Chronic Obstructive Pulmonary Disease [Internet]. 2011;
Available from: www.goldcopd.com
Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med. 2002;
136(9):691-700.
Gonzales R et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract
infections in adults: background, speci c aims, and methods. Ann Emerg Med. 2001; 37:690-
697.
Guidelines for Manegement of Adults with Hospital-acquired, Ventilator-associated, and Healtcare-
associated Pneumonia. Am J Respire Crit Care Med. 2005; 171:388-416.
Gupta RT, Kakarla RK, Kirshenbaum KJ, Tapson VF. D-dimers and efficacy of clinical risk estimation
algorithms: sensitivity in evaluation of acute pulmonary embolism. AJR Am J Roentgenol.
2009; 193(2):425-30.
Han MK. Medication adherence in COPD: what have we learned? Thorax [Internet]. 2009; 64(11):922-
3.
Heit JA, Silverstein MD, Mohr DN, Petterson TM, O´Fallon WM, Melton III LJ. Risk factors for deep vein
thrombosis and pulmonary embolism. Arch Intern Med. 2000; 160:809-15.
Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc
Biol. 2008; 28(3):370-2.
Heyland DK, Dodek P, Muscedere J, Day A, Cook D, for the Canadian Critical Care Trials Group.
Randomized trial of combination versus monotherapy for the empiric treatment of suspected
ventilator-associated pneumonia. Crit Care Med. 2008; 36(3).
Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008 Jun; 38(6):872-97.
Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J et al. Bene ts of omalizumab as add-on
therapy in patients with severe persistent asthma who are inadequately controlled despite best
available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005 Mar; 60(3):309-16.
Kalil AC, Cavalcanti M, Teixeira PJZ. Quantitative versus qualitative cultures of respiratory secretions for
clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database of
Systematic Reviews. 2008; 4(CD006482). DOI: 10.1002/14651858.CD006482.pub2.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ et al. Antithrombotic
therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;
141(2 Suppl):e419S-94S.
Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA et al. Comparison of low-intensity
warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of
recurrent venous thromboembolism. N Engl J Med. 2003; 349(7):631-9.
Kearon C. Natural history of venous thromboembolism. Circulation. 2003; 107(23 suppl 1):I-22-I-30.
Klok FA, Mos IC, Nijkeuter M, Righini M, Perrier A, Le Gal G et al. Simpli cation of the revised Geneva
score for assessing clinical probability of pulmonary embolism. Arch Intern Med. 2008;
168(19):2131-6.
Kobashi Y. Clinical analysis of community-acquired pneumonia in the elderly. Intern Méd. 2001;
40(8):703-707.
Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation 2005; 112(2):e28-
32.
Lama VN, Martinez FJ. Resting and exercise physiology in interstitial lung diseases. Clin Chest Med.
2004; 25(3):435-53.
Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in
adults with asthma. N Engl J Med. 1998 Oct 22; 339(17):1194-200.
Leidy NK. The Breathlessness, Cough, and Sputum Scale: The Development of Empirically Based
Guidelines for Interpretation. Chest [Internet]. 2003 Dec [cited 2010 Jun 28]; 124(6): 2182-91.
Lenzi L et al. In uenza pandêmico A (H1N1) 2009: fatores de risco para internamento. J Bras Pneumol.
2012; 38(1):57-65.
Leslie KO. My approach to interstitial lung disease using clinical, radiological and histopathological
patterns. J Clin Pathol. 2009; 62(5):387-401.
Light RW, Lee YCG. Textbook of pleural diseases. 2nd ed. London: Hodder Arnold, 2008.
Light RW. The Light criteria: the beginning and why they are useful 40 years later. Clin Chest Med.
2013 Mar; 34(1):21-6.
Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ,
Levy ML, Wani M, Woodhead MA. BTS guidelines for the management of community acquired
pneumonia in adults: update 2009. Thorax. 2009; 64: iii1-iii55 doi: 10.1136/thx.2009.121434
Lim WS. De ning community acquired pneumonia severity on presentation to hospital: an
international derivation and validation study. Thorax. 2003 may; 58:377-382.
Luiza M, Souza DM, Meneghini AC. Knowledge of and technique of using inhalation devices among
asthma patients and COPD patients. J Bras Pneumol. 2009; 35(May):824-31.
Lundgren FL, Stirbulov R, Jardim J. Como Acompanhar o Paciente com DPOC. Rio de Janeiro: AC
Farmacêutica, 2012.
Luppi F, Beghé B, Richeldi L. Acute exacerbations of chronic obstructive pulmonary disease: are
antibiotics needed? American journal of respiratory and critical care medicine [Internet]. 2010
Jan; 181(2):102-3.
Machado A. A Infecção pelo vírus In uenza A (H1N1) de origem suína: como reconhecer, diagnosticar
e prevenir. J Bras Pneumol. 2009; 35(5):464-469.
Mandell LA et al. Infectious Diseases Society / American Thoracic Society Consensus Guidelines on the
Management of Community-Acquired Pneumonia in Adults. Clin Infec Diseases. 2007; 44:S27-
72.
Marchi E, Lundgren F, Mussi R. Derrame pleural parapneumônico e empiema. Jornal Brasileiro de
Pneumologia. 2006; 32(Supl 4):S190-S196.
Martin-Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, Restrepo MI,
Rello J. Combination antibiotic therapy with macrolides improves survival in intubated patients
with community-acquired pneumonia. Intensive Care Med. 2010; 36:612-620.
McGrath EE, Blades Z, Needham J, Anderson PB. A systematic approach to the investigation and
diagnosis of a unilateral pleural effusion. Int J Clin Pract. 2009 Nov; 63(11):1653-9.
Menéndez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA. Markers of treatment failure in
hospitalised community acquired pneumonia. Thorax. 2008; 63(5):447-52.
Meyer KC Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med. 2007; 28(5):546-
60.
Micek ST, Welch EC, Khan J et al. Empiric combination antibiotio-therapy is associated with improved
outcome against sepsis due to Gram-negative bacteria: A retrospective analysis. Antimicrob
Agents Chemother. 2010; 54:1742-1748.
Miniati M, Pistolesi M, Marini C, Di Ricco G, Formichi B, Prediletto R et al. Value of perfusion lung scan
in the diagnosis of pulmonary embolism: results of the prospective investigative study of acute
pulmonary embolism diagnosis (PISA-PED). Am J Respir Crit Care Med. 1996; 154(5):1387-93.
Mukherjee S, Van Pittus DG, Spiteri M. Diffuse parenchymal lung disease: a practical overview. Isa a
lung biopsy necessary for management? Breathe. 2008; 4(3):233-239.
Neuhaus T, Ewig S. De ning severe community-acquired pneumonia. Med Clin North Am. 2001;
85(6):1413-1425.
Nicolini A et al. Pneumonia associada a in uenza A (H1N1). J Brasil Pneumol. 2011; 37(5):621-627. Niewoehner DE. Outpatient Management of Severe COPD. The New England journal of medicine.
2010; 326(15):1407-16.
O’Byrne PM, Reddel HK, Eriksson G, Ostlund O, Peterson S, Sears MR et al. Measuring asthma control: a
comparison of three classi cation systems. Eur Respir J. 2010 Aug; 36(2):269-76.
Oliveira M, Muniz M, Santos L, Faresin SM, Fernandes AL. Custo efetividade de programa de educação
para adultos asmáticos atendidos em hospital escola de instituição pública. J Pneumonol.
2002; 21(2):71-6.
Pauwels RA, Lofdahl CG, Postma DS, Tatters eld AE, O’Byrne P, Barnes PJ et al. Effect of inhaled
formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids
Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997 Nov 13;
337(20):1405-11.
Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E et al. Worldwide trends in the prevalence
of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood
(ISAAC). Thorax. 2007 Sep; 62(9):758-66.
Pereira C, Neder J. II Consenso Brasileiro sobre Espirometria. Jornal de Pneumologia. 2002; 28(3):S2-
S115.
Péreza RP, Banderab FH, Gonzáleza FA, Landalucec AF, Ricod JCS, Cánvasc CP, Reya CC, Ortegaa MJC.
Documento de consenso sobre el diagnóstico y tratamiento de la faringoamigdalitis aguda. An
Pediatr (Barc). 2011; 75(5):342. e1--342. e13.
Polkey MI, Rabe KF. Chicken or egg: physical activity in COPD revisited. The European respiratory
journal: official journal of the European Society for Clinical Respiratory Physiology [Internet].
2009; 33(2):227-9.
Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006 Apr 1;
73(7):1211-20.
Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG et al. Randomised controlled trial of
montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients
with asthma. Thorax. 2003 Mar; 58(3):211-6.
Raghu G, Brown KK. Interstitial lung disease: clinical evaluation and keys to an accurate diagnosis. Clin
Chest Med. 2004; 25(3):409-19.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al. An official ATS/ERS/JRS/ALAT
statement: idiopathic pulmonary brosis: evidence-based guidelines for diagnosis and
management. Am J Respir Crit Care Med. 2011; 183(6):788-824.
Rahman NM, Chapman SJ, Davies RJ. Pleural effusion: a structured approach to care. Br Med Bull.
2005 Mar 14; 72:31-47.
Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW et al. An official American
Thoracic Society/European Respiratory Society statement: asthma control and exacerbations:
standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care
Med. 2009 Jul 1; 180(1):59-99.
Rello J, Catalán M, Díaz E, Bodí M, Alvarez B Associations between empirical antimicrobial therapy at
the hospital and mortality in patients with severe community-acquired pneumonia. Intensive
Care Med. 2002; 28(8):1030-5.
Rello J, Lode H, Cornaglia G, Masterton R. The VAP Care Budle Contributors. A European care budle for
prevention of ventila-tor-associated pneumonia. Intensive Care Med. 2010; 36: 773-80.
Rello J, Sa-Borges M, Correa H et al. Variations in etiology of ventilator-associated pneumonia across
four treatment sites: Implications for antimicrobial prescribing practices. Am J Respir Crit Care
Med. 1999; 160:608-13.
Requejo HI, Braz J. C-reactive protein in the diagnosis of community-acquired pneumonia. Infect Dis.
2003; 7(4):241-4.
Ribeiro SA et al. Síndrome respiratória aguda grave causada por In uenza A (subtipo H1N1). J Bras
Pneumol. 2010; 36(3):386-9.
Rice KL, Dewan N, Bloom eld HE, Grill J, Schult TM, Nelson DB et al. Disease Management Program for
Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. American Journal of
Respiratory and Critical Care Medicine [Internet]. 2010 Jan [cited 2010 Sep 15]; (C):1-41.
Richard M, Rosenfeld RM, Andes D, Neil B, Cheung D, Eisenberg S, Ganiats TG, Gelzer A, Hamilos D,
Haydon III RC, Hudgins PA, Jones S, Krouse HJ, Lee LH, Mahoney MC, Marple BF, Mitchell JP,
Nathan R, Shiffman RN, Smith TL, Witsell DL. Clinical practice guideline: Adult sinusitis.
Otolaryngology–Head and Neck Surgery. 2007; 137:S1-S31.
Ringbaek T, Martinez G, Lange P. A Comparison of the Assessment of Quality of Life with CAT, CCQ, and
SGRQ in COPD Patients Participating in Pulmonary Rehabilitation. COPD: Journal of Chronic
Obstructive Pulmonary Disease [Internet]. 2012 Feb [cited 2012 Feb 26]; 9(1):12-5.
Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute
asthma: a systematic review with meta-analysis. Thorax. 2005 Sep; 60(9):740-6.
Rodrigo GJ. Predicting response to therapy in acute asthma. Curr Opin Pulm Med. 2009 Jan; 15(1):35-
8.
Rodriguez A, Lisboa T, Stijn B, Martin-Loeches I, Sole-Violan J, Mendoza D, Rello J. Mortality in ICU
patients with bacterial community-acquired pneumonia: when antibiotics are not enough.
Intensive Care Med. 2009; 35:430-438. DOI 10.1007/s00134-008-1363-6
Ryu JH, Olson EJ, Midthun DE, Swensen SJ. Diagnostic approach to the patient with diffuse lung
disease. Mayo Clin Proc. 2002; 77:1221-1227.
Santos LA, Oliveira MA, Faresin SM, Santoro IL, Fernandes AL. Direct costs of asthma in Brazil: a
comparison between controlled and uncontrolled asthmatic patients. Braz J Med Biol Res. 2007
Jul; 40(7):943-8.
SBPT. Diretrizes de doenças pulmonares intersticiais. J Bras Pneumol. 2012; (supl 2): 1-133.
Scheid DC, Hamm RM. Acute Bacterial Rhinosinusitis in Adults: Part I. Evaluation. Am Fam Physician.
2004; 70:1685-92.
Scheid DC, Hamm RM. Acute Bacterial Rhinosinusitis in Adults: Part II. Treatment. Am Fam Physician.
2004; 70(1):697-704, 1711-12.
Senjyu H, Tanigushi H, Honda S, Ariyoshi K, Yosa Y. Development of an activity of daily living scale for
patients with COPD: The Activity of Daily Living Dyspnea scale. Respirology. 2009; 14(May
2008):429-35.
Silva LCC. Pneumologia: princípios e prática. Artmed Editora AS. 2012; 283.
Siow JK, Alshaikh NA, Balakrishnan A, Chan KO, Chao SS, Goh LG, Hwang SYJ, Lee CYJ, Leong JL, Lim L,
Menon A, Sethi DS, Tan H, Wang DY. Ministry of Health Clinical Practice Guidelines:
Management of Rhinosinusitis and Allergic Rhinitis. Singapore Med J. 2010; 51(3):190.
Smith PR. What diagnostic tests are needed for community-acquired pneumonia? Med Clin North Am.
2001; 85(6):1381-1396.
Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes para o Manejo da Asma da Sociedade
Brasileira de Pneumologia e Tisiologia. J Bras Pneumol. 2012; 38(supl 1):S1-S46.
Sociedade Brasileira de Pneumologia e Tisiologia. III Diretrizes para Tuberculose da Sociedade
Brasileira de Pneumologia e Tisiologia. J Bras Pneumol. 2009; 35(10):1018-1048.
Sole D, Camelo-Nunes IC, Wandalsen GF, Pastorino AC, Jacob CM, Gonzalez C et al. Prevalence of
symptoms of asthma, rhinitis, and atopic eczema in Brazilian adolescents related to exposure
to gaseous air pollutants and socioeconomic status. J Investig Allergol Clin Immunol. 2007;
17(1):6-13.
Sperber SJ, Turner RB, Sorrentino JV et al. Effectiveness of pseudoephedrine plus acetaminophen for
the treatment of symptoms attributed to the paranasal sinuses associated with the common
cold. Arch Fam Med. 2000; 9:978-985.
Stein PD, Chenevert TL, Fowler SE, Goodman LR, Gottschalk A, Hales CA et al. (PIOPED III
Investigators). Gadolinium-enhanced magnetic resonance angiography for pulmonary
embolism: a multicenter prospective study (PIOPED III). Ann Intern Med. 2010; 152(7):434.
Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD et al. (PIOPED II Investigators).
Multidetector Computed Tomography for Acute Pulmonary Embolism. N Engl J Med. 2006;
354(22):2317-27.
Stein PD, Henry JW. Clinical characteristics of patients with acute pulmonary embolism strati ed
according to their presenting syndromes. Chest. 1997; 112(4):974-9.
Tantucci C, Modina D. Lung function decline in COPD. International Journal of Chronic Obstructive
Pulmonary Disease [Internet]. 2012 Jan; 7:95-9.
Tapson VF. Acute Pulmonary Embolism. N Engl J Med. 2008; 358(10):1037-52.
Tapson VF. Treatment of pulmonary embolism: anticoagulation, thrombolytic therapy, and
complications of therapy. Crit Care Clin. 2011; 27:825-39.
Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB et al. A new perspective on
concepts of asthma severity and control. Eur Respir J. 2008 Sep; 32(3):545-54.
Teixeira C, Cabral C, Hass J. Patients admitted to the ICU for acute exacerbation of COPD: two-year
mortality and functional status. Jornal Brasileiro de Pneumologia [Internet]. 2011 [cited 2012
May 27]; 37(December 2010):334-40.
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe
asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J.
2003 Sep; 22(3):470-7.
The PIOPED Investigators. Values of the ventilation/perfusion scan in acute pulmonary embolism –
results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA.
1990; 263(20):2753-9.
Torbicki A, Chairperson, Perrier A, Konstantinides S, Agnelli G, Galie N et al. Guidelines on the
diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis
and Management of Acute Pulmonary Embolism of the Wicki J, Perneger TV, Junod AF,
Bounameaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the
emergency ward: a simple score. Arch Intern Med. 2001; 161(1): 92-7.
Ulrik CS, Backer V. Nonreversible air ow obstruction in life-long nonsmokers with moderate to severe
asthma. Eur Respir J. 1999 Oct; 14(4):892-6.
Vestbo J, Edwards L, Scanlon PD, Yates JC, Agusti A, Bakke P et al. Changes in forced expiratory volume
in 1 second over time in COPD. The New England journal of medicine [Internet]. 2011 Sep 29;
365(13):1184-92.
Vincent Lo Re III. Hot Topics Infectious Diseases. Hanley & Belfus, Inc., 2004.
Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. The European
respiratory journal: official journal of the European Society for Clinical Respiratory Physiology
[Internet]. 2009; 33(2):262-72.
Welte T. Optimising treatment for COPD – new strategies for combination therapy. International
journal of clinical practice [Internet]. 2009; 63(8):1136-49.
Wenzel S, Fahy J, Irvin C, Peters S, Sze er S. Proceedings of the ATS workshop on refractory asthma:
current understanding, recommendations, and unanswered questions. American Thoracic
Society. Am J Respir Crit Care Med. 2000 Dec; 162(6):2341-51.
Wipht JE. Diagnosing Pneumonia by Physical Examination. Arch Intern Med. 1999; 159:1082-1087.
Wong CL, Holroyd-Leduc J, Straus SE. Does this patient have a pleural effusion? JAMA. 2009 Jan 21;
301(3):309-17.
Woodhead M, Blasi F, Ewig S, Huchon G, Leven M et al. Guidelines for the management of adult lower
respiratory tract infections. Clin Microbiol Infect. 2011; 17(Suppl. 6): E1–E59.
World Health Organization. 23-valent pneumococcal polysaccharide vaccine WHO position paper.
WER. 83(42):373-84.
World Health Organization. Pneumococcal conjugate vaccine for childhood immunization Who
position paper. Wkly Epidemiol Rec. 2007; 82(12):93-104.
World Health Organization. Treatment of Tuberculosis. Guidelines. Fourth edition. Geneve: World
Health Organization, 2009.
Wrightson JM, Helm EJ, Rahman NM, Gleeson FV, Davies RJ. Pleural procedures and pleuroscopy.
Respirology. 2009 Aug;14(6):796-807.
Yataco JC, Dweik RA. Pleural effusions: evaluation and management. Cleve Clin J Med. 2005 Oct;
72(10):854-6, 858, 862-4 passim.
Yip NH, Yuen G, Lazar EJ, Regan BK, Brinson MD, Taylor B et al. Analysis of hospitalizations for COPD
exacerbation: opportunities for improving care. COPD [Internet]. 2010 Apr [cited 2010 Sep 30];
7(2):85-92.
Zompatori M, Bnà C, Poletti V, Spaggiari E, Ormitti F, Calabrò E, Tognini G, Sverzellati N. Diagnostic
imaging of diffuse in ltrative disease of the lung. Respiration. 2004; 71(1):4-19.
OceanofPDF.com